Puma Biotechnology Inc. (PBYI)
Puma Biotechnology Max Pain By Strike
PBYI trades at $5.73, 14.6% above the near-term max pain of $5 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$90), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Puma Biotechnology Max Pain By Expiry
Max pain for PBYI shows a downward trend from 90 to 2.5, indicating bearish sentiment or hedging activity. The 500% spread signals divergent expectations across timeframes. Most levels below 5.73 may cap rallies. Strong magnetic level at 3 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Aug 15, 2025 | 5 | -0.73 (-12.74%) |
Sep 19, 2025 | 2.5 | -3.23 (-56.37%) |
Oct 17, 2025 | 2.5 | -3.23 (-56.37%) |
Dec 19, 2025 | 2.5 | -3.23 (-56.37%) |
Jan 16, 2026 | 90 | 84.27 (1470.68%) |
Mar 20, 2026 | 2.5 | -3.23 (-56.37%) |